Skip to main content
    H

    Humacyte Inc (HUMAW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.00
    +0.00 (+0.00%)

    Last updated: Aug 26, 2026 at 5:00 PM ET

    Earnings

    Upcoming Estimates

    Results pendingPeriod ending Jun 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $1.11M
    Range$780.00K - $1.59M
    5 analysts
    Results pendingPeriod ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $2.18M
    Range$1.40M - $2.98M
    5 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -N/AN/A-----
    Sep 26EST
    Date TBD
    -N/AN/A-----
    Jun 26EST
    Date TBD
    -N/AN/A-----
    Jun 21
    Reported Sep 30
    -$0.72N/AN/A-----6.2%
    Mar 21
    Reported Jun 30
    -$0.76N/AN/A----+6.7%
    Dec 20
    Reported Mar 31
    -$0.91N/AN/A-----
    Jun 20
    Reported Sep 30
    -$3.07N/AN/A-----
    Mar 20
    Reported Jun 30
    -$0.68N/AN/A-----
    Dec 19
    Reported Mar 31
    -$0.81N/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-6649.00%
    ROE-548.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta2.47Avg VolumeN/A
    52-Week High$0.4052-Week Low$0.00

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 89.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 31.7, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.01
    SMA 20$0.01
    SMA 50$0.01
    SMA 200$0.08
    EMA 10$0.00
    EMA 20$0.01
    EMA 50$0.02
    EMA 200$0.10

    MACD

    Line: -0.00Signal: -0.00Hist: -0.00

    ADX

    ADX: 35.2+DI: 15.8-DI: 40.7

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$0.01

    Bollinger Bands

    Upper Band$0.01
    Lower Band$0.00
    %B Position14819%(Upper)
    Band Width-0.09

    RSI (14-Day)

    Neutral
    31.7

    Momentum Oscillators

    Stoch %K8.2
    Stoch %D17.8
    Williams %R-100.0
    ROC (10d)-85.0%
    Momentum-0.01
    CCI (20d)-240.3
    MFI (14d)29.9

    Volatility Measures

    ATR (14d)$0.00(248.9%)
    StdDev (20d)0.00
    Hist Vol458.6%(High)

    Volume Flow

    VWAP$0.00
    OBV-257.1K
    AD Line1.0M
    CMF (20d)0.211

    Volume Metrics

    Avg Vol (20d)53.1K
    Vol RatioN/A
    VWMA (20d)$0.01

    Pivot Points

    R3$0.01
    R2$0.00
    R1$0.00
    Pivot Point$0.00
    S1$-0.00
    S2$-0.00
    S3$-0.00

    Advanced Oscillators

    TSI-25.53
    Ultimate Osc41.3
    KST-337.98

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HUMAW

    News

    No news available

    Company news will appear here when available

    HUMAW Profitability: Margins, ROIC and FCF

    Humacyte (HUMAW) has an operating margin of -6649.0% and a net margin of 0.0%.

    Operating margin
    -6649.0%
    Net margin
    0.0%
    ROE
    -548.0%
    HUMAW financial statements

    Humacyte Competitors

    The companies most similar to Humacyte (HUMAW) include Avita Medical, HCW Biologics and Artivion.

    Sector: Healthcare

    HUMAW Bull Case vs Bear Case

    Bull case

    • HUMAW grew quarterly revenue 34.9% year over year.

    Updated Aug 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.